The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
Author(s) -
Moira Lewitt,
Gary W. Boyd
Publication year - 2019
Publication title -
biochemistry insights
Language(s) - English
Resource type - Journals
ISSN - 1178-6264
DOI - 10.1177/1178626419842176
Subject(s) - paracrine signalling , autocrine signalling , growth factor , biology , nervous system , insulin like growth factor , endocrine system , neuroscience , receptor , insulin , signal transduction , central nervous system , microbiology and biotechnology , bioinformatics , endocrinology , hormone , genetics
The insulin-like growth factors (IGF-I and IGF-II) and their receptors are widely expressed in nervous tissue from early embryonic life. They also cross the blood brain barriers by active transport, and their regulation as endocrine factors therefore differs from other tissues. In brain, IGFs have paracrine and autocrine actions that are modulated by IGF-binding proteins and interact with other growth factor signalling pathways. The IGF system has roles in nervous system development and maintenance. There is substantial evidence for a specific role for this system in some neurodegenerative diseases, and neuroprotective actions make this system an attractive target for new therapeutic approaches. In developing new therapies, interaction with IGF-binding proteins and other growth factor signalling pathways should be considered. This evidence is reviewed, gaps in knowledge are highlighted, and recommendations are made for future research.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom